Abstract:Nucleic acid-based therapy has emerged as a revolutionary methodology for treatment of the diseases related to protein dysfunction; however, lack of systemically applicable synthetic delivery systems limits its current usage in local applications, particularly for DNA-based therapy with regard to the poor bioavailability in the systemic administrations. To overcome this obstacle, we compiled multiple chemistry-based strategies into the manufacture of the gene delivery formulations to pursue improved tolerability of DNA to the enzymatic degradation in the biological milieu and prolonged retention in the systemic circulation. Here, we constructed a distinctive multilayered functional architecture: plasmid DNA (pDNA) was electrostatically complexed with cationic poly(lysine) (polyplex) as the interior pDNA reservoir, which was further cross-linked by redox-responsive disulfide cross-linking to minimize the occurrence of polyplex disassembly through exchange reaction with the biological charged,components. Still, the pDNA reservoir was spatially protected by a sequential thermoresponsive poly(N-isopropylacrylamide) palisade as the intermediate barrier and a biocompatible hydrophilic poly(ethylene glycol) (PEG) shell with the aim of preventing the accessibility of the biological species, particularly the nuclease degradation to the pDNA payload. Subsequent investigations validated the utilities of these strategies in accomplishing prolonged blood retention. In an attempt to apply this method for tumor therapy, ligand cyclic (Arg-Gly-Asp) peptide was attached at the distal end of PEG, validating prompted tumor-targeted delivery and gene expression of the loaded antiangiogenic gene at the targeted tumor cells and accordingly exerting antiangiogenesis of the tumors for abrogation of tumor growth. Together with its excellent safe profile, the proposed formulation suggests potential utility as a practical gene delivery system for treatment of intractable diseases.

Tumor targeting polypeptide and application

Targeting Tumor Cells by Natural Anti-Carbohydrate Antibodies Using Rhamnose-Functionalized Liposomes.

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

Application of EGF-like Growth Factor-derived Tumor-homing Peptide for Antineoplastic Protein

Tumor-homing peptide and its utility for advanced cancer medicine

Programmable Assembly of Multivalent DNA‐Protein Superstructures for Tumor Imaging and Targeted Therapy

Cathepsin D antigen polypeptide and application thereof as well as detecting kit containing polypeptide

Application of Elastin-Like Polypeptide in Tumor Therapy

Tumor-targeted gene therapy: strategies for the preparation of ligand–polyethylene glycol–polyethylenimine/DNA complexes

Transmembrane modification of tumor vascular targeting peptide A7R as molecular cargo delivery tool

Polypeptides-Based Nanocarriers in Tumor Therapy

Tumor Targeting and Microenvironment-Responsive Multifunctional Fusion Protein for Pro-Apoptotic Peptide Delivery

Targeting Matrix Metalloproteinases And Endothelial Cells With A Fusion Peptide Against Tumor

Application of reproductive hormone peptides for tumor targeting.

High polymer material for complexing copper ions and anti-tumor application thereof

Design of Cell-Specific Targeting Peptides for Cancer Therapy

Construction Of A Tumor Cell-Targeting Non-Viral Gene Delivery Vector With Polyethylenimine Modified With Rgd Sequence-Containing Peptide

Peptide-Mediated Nano Drug Delivery System for Tumor Targeting

Acid Active Receptor-Specific Peptide Ligand for in Vivo Tumor-Targeted Delivery

Self‐Assembled Bifunctional Peptide As Effective Drug Delivery Vector with Powerful Antitumor Activity

New Thinking of Research on Vascular Endothelium-targeted Anti-tumor Polypeptides